Fox Protein Footprinting Services
Easily Explore the Advantages of Radical Protein Footprinting
You can take advantage of GenNext’s patented and novel Fox technology through our convenient contract services program. This streamlined services program is the fastest and most economical route to access this robust and state-of-the-art HOS analytical method.
Complement your traditional HOS methods or begin a totally new route to modern HOS analysis using GenNext’s services. We will deliver novel and actionable information regarding the protein structure of your molecule to help you discover and build more effective and safer therapeutics.

Advantages of the Services Program
Solve valuable and intractable problems—while constraining upfront costs and risk—as you evaluate the impact of Fox HOS on your research. Our Services option is a convenient and cost-effective means for you to validate Fox Technology advantages over alternative HOS methods while becoming experienced and proficient in the use of this emerging technique.
Contact us to gain access to Fox technology via our service program.
Customized Programs
Each program is tailored to meet your HOS analytical needs with an affordable fee-for-service structure. Using a research collaboration model, we will define a specific multi-phase approach that facilitates timely turn-around of valuable research data. Regularly scheduled checkpoint meetings enable collaborative review of experimental results and further refinement of each program.
Start our collaboration now so we can custom build your HOS service package.
Preferential System Pricing
In addition to obtaining valuable research data and results, as a service client, you qualify for advanced instrumentation access at preferential pricing when you are ready to bring the analytical power of Fox technology in-house.
Contact us now to learn about special system pricing for service project customers.
Monoclonal Antibody Services

Fox Systems revolutionize monoclonal antibody (mAb) design, production, and biosimilar development by providing detailed, residue-level analysis of antigen-antibody interactions within days. Researchers have a powerful tool to streamline drug development processes, potentially reducing time-to-market and improving the efficacy of new treatments.